A New Prognostic Indicator of Immune Microenvironment and Therapeutic Response in Lung Adenocarcinoma Based on Peroxisome-Related Genes

Figure 8

Validation of signature genes with immunohistochemistry. (a) ABCD1. (b) ACAT1. (c) ACSL1. (d) ACSL3. (e) CAT. (f) LDHA.

(a)

(b)

(c)

(d)

(e)

(f)